The CGC test is used in conjunction with other screening tools by some therapy dog organizations for
selecting potential therapy dogs.
Not exact matches
«DNA barcoding has the
potential to advance the science of
selecting nanoparticles for delivering gene
therapies,» said James Dahlman, an assistant professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University and the study's principal investigator.
«This study illustrates the
potential of gaining fundamental insights into brain function while helping patients with debilitating diseases, and provides us with a powerful way of
selecting targets based on their connectivity to other regions that can be widely applied to help guide brain stimulation
therapy across multiple neurological and psychiatric disorders.»
«Our findings of this
potential biomarker are exciting — it means we are closer to being able to
select therapies more specifically for a patient with colon cancer.
«Therefore, any
potential promising results get diluted because novel
therapies are not administered to those
select patients who are most likely to respond, based on their tumors» molecular profile.
«This project was
selected for PCORI funding for its
potential to fill an important gap in our understanding of long - term opioid
therapy and to give people living with chronic pain useful information to help them weigh the effectiveness and safety of their care options,» said PCORI executive director Joe Selby, MD, MPH.